Binding of warfarin influences the acid-base equilibrium of H242 in Sudlow Site I of human serum albumin

Photochemistry and Photobiology

Volumn 82, Issue 5, 2006, Pages 1365-1369

  Perry, Jennifer L ^a   Goldsmith, Michael R ^b   Williams, T Richard ^b   Radack, Kyle P ^b   Christensen, Trine ^b   Gorham, Justin ^b   Pasquinelli, Melissa A ^b   Toone, Eric J ^b   Beratan, David N ^b   Simon, John D ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM ALBUMIN; WARFARIN;

ACID BASE BALANCE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; CONFERENCE PAPER; HUMAN; KINETICS; METABOLISM; PROTEIN BINDING; PROTEIN CONFORMATION;

ACID-BASE EQUILIBRIUM; BINDING SITES; HUMANS; KINETICS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; SERUM ALBUMIN; WARFARIN;

MOPS;

EID: 33750726406     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/2006-02-23-RA-811     Document Type: Conference Paper

References (35)

1. Peters, T. (1996) All About Albumin. Academic Press, New York.
2. Dockal, M., D. C. Carter and F. Rüker (1999) The three recombinant domains of human serum albumin - structural characterization and ligand binding properties. J. Biol. Chem. 274, 29303-29310.
3. Dockal, M., M. Chang, D. C. Carter and F. Rüker (2000) Five recombinant fragments of human serum albumin - Tools for the characterization of the warfarin binding site. Protein Sci. 9, 1455-1465.
4. Chemical Computing Groups, Inc. (2004) MOE, Ed. 03. Chemical Computing Group, Inc., Montreal, Quebec, Canada.
5. Brooks, B. R., R. E. Bruccoleri, B. D. Olafson, D. J. States, S. Swaminathan and M. Karplus (1983) Charmm: A program for macromolecular energy, minimization, and dynamics calculations. J. Comp. Chem. 4, 187-217.
6. Il'ichev, Y. V., J. L. Perry and J. D. Simon (2002) Interaction of ochratoxin a with human serum albumin: Preferential binding of the dianion and ph effects. J. Phys. Chem. B 106, 452-459.
7. Il'ichev, Y. V., J. L. Perry, F. Ruker, M. Dockal and J. D. Simon (2002) Interaction of ochratoxin a with human serum albumin: Binding sites localized by competitive interactions with the native protein and its recombinant fragments. Chem. Bio. Inter. 141, 275-293.
8. Perry, J. L., Y. V. Il'ichev, V. R. Kempf, J. McClendon, G. Park, R. A. Manderville, F. Ruker, M. Dockal and J. D. Simon (2003) Binding of ochratoxin a derivatives to human serum albumin. J. Phys. Chem. B 107, 6644-6647.
9. Perry, J. L., T. Christensen, M. R. Goldsmith, E. J. Toone, D. N. Beratan and J. D. Simon (2003) Binding of ochratoxin a to human serum albumin stabilized by a protein-ligand ion pair. J. Phys. Chem. B 107, 7884-7888.
10. Perry, J. L., M. R. Goldsmith, M. A. Peterson, D. N. Beratan, G. Wozniak, F. Ruker and J. D. Simon (2004) Structure of the ochratoxin a binding site within human serum albumin. J. Phys. Chem. B 108, 16960-16964.
11. Chu, F. S. (1971) Interaction of ochratoxin a with bovine serum albumin. Arch. Biochem. Biophys. 147, 359-366.
12. Chu, F. S. (1974) Studies on ochratoxins. CRC Critical Rev. Toxicol. 2, 499-524.
13. Gillman, I. G., T. N. Clark and R. A. Manderville (1999) Oxidation of ochratoxin a by an fe-porphyrin system: Model for enzymatic activation and DNA cleavage. Chem. Res. Toxicol. 12, 1066-1076.
14. Xiao, H., S. Madhyastha, R. R. Marquardt, S. Li, J. K. Vodela, A. A. Frohlich and B. W. Kemppainen (1996) Toxicity of ochratoxin a, its opened lactone form and several of its analogs: Structure-activity relationships. Toxicol. Appl. Pharm. 137, 182-192.
15. Pitout, M. J. (1968) The effect of ochratoxin a on glycogen storage in the rat liver. Toxicol. Appl. Pharmacol. 13, 299-306.
16. Uchiyama, S. and Y. Saito (1987) Protein-binding potential of ochratoxin a in vitro and its fluorescence enhancement. J. Food Hyg. Soc. Jpn. 28, 453-460.
17. Uchiyama, S., Y. Saito and M. Uchiyama (1985) Protein-binding of ochratoxin a and its extractability from proteinaceous food. J. Food Hyg. Soc. Jpn. 26, 651-657.
18. Shapiro, S. (1953) Warfarin sodium derivative intravenous hypoprothrombinemia inducing agent. Angiology 4, 380-390.
19. Mach, H., C. R. Middaugh and R. V. Lewis (1992) Statistical determination of the average values of the extinction coefficients of tryptophan and tyrosine in native proteins. Anal. Biochem. 200, 74-80.
20. Goldberg, R. N., N. Kishore and R. M. Lennen (2002) Thermodynamic quantities for the ionization reactions of buffers. J. Phys. Chem. Ref. Data 31, 231-370.
21. Thompson, M. (2004) Argus Lab, Ed. 4.0.1. Planaria Software LLC., Seattle, WA.
22. Petitpas, I., A. A. Bhattacharya, S. Twine, M. East and S. Curry (2001) Crystal structure analysis of warfarin binding to human serum albumin - Anatomy of drug site 1. J. Biol. Chem. 276, 22804-22809.
23. (1999) Sybyl, Ed. 6.5. Tripos Inc., St. Louis, MO.
24. Morris, G. M., D. S. Goodsell, R. S. Halliday, R. Huey, W. E. Hart, R. K. Belew and A. J. Olson (1998) Automated docking using a lamarckian genetic algorithm and and empirical binding free energy function. J. Comput. Chem. 19, 1639-1662.
25. Ishihama, Y., Y. Oda and N. Asakawa (1994) Microscale determination of dissociation-constants of multivalent pharmaceuticals by capillary electrophoresis. J. Pharm. Sci. 83, 1500-1507.
26. Bos, O. J. M., M. J. E. Fischer, J. Wilting and L. H. M. Janssen (1989) Mechanism by which warfarin binds to human serum albumin - Stopped-flow kinetic experiments with 2 large fragments of albumin. Biochem. Pharmacol. 38, 1979-1984.
27. Bos, O. J. M., J. P. M. Remijn, M. J. E. Fischer, J. Wilting and L. H. M. Janssen (1988) Location and characterization of the warfarin-binding site of human serum albumin - A comparative study of 2 large fragments. Biochem. Pharmacol. 37, 3905-3909.
28. Leavitt, S. and E. Freire (2001) Direct measurement of protein binding energetics by isothermal titration calorimetry. Curr. Opin. Struct. Biol. 11, 560-566.
29. Petersen, C. E., C. E. Ha, S. Curry and N. V. Bhagavan (2002) Probing the structure of the warfarin-binding site on human serum albumin using site-directed mutagenesis. Proteins 47, 116-125.
30. Watanabe, H., U. Kragh-Hansen, S. Tanase, K. Nakajou, M. Mitarai, Y. Iwao, T. Maruyama and M. Otagiri (2001) Conformational stability and warfarin-binding properties of human serum albumin studied by recombinant mutants. Biochem. J. 357, 269-274.
31. Khan, M. M., S. Muzammil and S. Tayyab (2000) Role of salt bridge(s) in the binding and photoconversion of bilirubin bound to high affinity site on human serum albumin. DBA-Protein Struct. M. 1479, 103-113.
32. Liu, J., J. Tian, X. Tian, Z. Hu and X. Chen (2004) Interaction of isofraxidin with human serum albumin. Bioorgan. Med. Chem. 12, 469-474.
33. Ghuman, J., P. A. Zunszain, I. Petitpas, A. A. Bhattacharya, M. Otagiri and S. Curry (2005) J. Molecular Biol. Structural basis of the drug-binding specificity of human serum albumin. 353, 38-52.
34. Sawas, A. H., S. N. Pentyala and M. J. Rebecchi (2004) Binding of volatile anesthetics to serum albumin: Measurements of enthalpy and solvent contributions. Biochemistry 43, 12675-12685.
35. Humphrey, W., A. Dalke and K. Schulten (1996) Vmd-visual molecular dynamics. J. Mol. Graphics 14, 33-38.